FibroGen Stock Went Down By Over 31% In The Last 21 Sessions
Nasdaq-listed FibroGen has recently experienced a significant drop in their shares of 31.8% in less than one month, this steep decline is especially shocking given that Nasdaq itself has seen an increase of 0.41% in the same period. This downfall is characterized by three consecutive sessions of losses where FibroGen fell from its high point…